(Circulation. 2001;103:2922.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis
The Los Angeles Atherosclerosis Study
From the Department of Preventive Medicine (Institute for Prevention Research), Keck School of Medicine, University of Southern California (J.H.D., K.M.D., P.S., A.S.); the Departments of Medicine (M.N., K.H., S.H.-L., G.H., X.W., T.D., A.M.F.) and Laboratory and Experimental Pathology (T.D.), School of Medicine, University of California Los Angeles; and the Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center (C.N.B.M.), Los Angeles, Calif.
Correspondence to Professor J. Dwyer, University of Southern California, 1000 S Fremont Ave, Unit 8, Alhambra, CA 91803. E-mail jimdwye{at}hsc.usc.edu
Background—Carotenoids are hypothesized to explain some of the protective effects of fruit and vegetable intake on risk of cardiovascular disease. The present study assessed the protective effects of the oxygenated carotenoid lutein against early atherosclerosis.
Methods and Results—Epidemiology: Progression of intima-media thickness (IMT) of the common carotid arteries over 18 months was determined ultrasonographically and was related to plasma lutein among a randomly sampled cohort of utility employees age 40 to 60 years (n=480). Coculture: The impact of lutein on monocyte response to artery wall cell modification of LDL was assessed in vitro by quantification of monocyte migration in a coculture model of human intima. Mouse models: The impact of lutein supplementation on atherosclerotic lesion formation was assessed in vivo by assigning apoE-null mice to chow or chow plus lutein (0.2% by weight) and LDL receptor–null mice to Western diet or Western diet plus lutein. IMT progression declined with increasing quintile of plasma lutein (P for trend=0.007, age-adjusted; P=0.0007, multivariate). Covariate-adjusted IMT progression (mean±SEM) was 0.021±0.005 mm in the lowest quintile of plasma lutein, whereas progression was blocked in the highest quintile (0.004±0.005 mm; P=0.01). In the coculture, pretreatment of cells with lutein inhibited LDL-induced migration in a dose-dependent manner (P<0.05). Finally, in the mouse models, lutein supplementation reduced lesion size 44% in apoE-null mice (P=0.009) and 43% in LDL receptor–null mice (P=0.02).
Conclusions—These epidemiological, in vitro, and mouse model findings support the hypothesis that increased dietary intake of lutein is protective against the development of early atherosclerosis.
Key Words: atherosclerosis • epidemiology • carotid arteries • ultrasonography • diet • lutein
This article has been cited by other articles:
 |
|
 |
|
  K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, K. Umezawa, S. Ohno, Y. Oike, and S. Ishida Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2555 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, S. L Connor, E. J Johnson, M. L Klein, S. Hughes, and W. E Connor Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration Am. J. Clinical Nutrition, March 1, 2007; 85(3): 762 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Herron, M. M. McGrane, D. Waters, I. E. Lofgren, R. M. Clark, J. M. Ordovas, and M. L. Fernandez The ABCG5 Polymorphism Contributes to Individual Responses to Dietary Cholesterol and Carotenoids in Eggs J. Nutr., May 1, 2006; 136(5): 1161 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Kabagambe, J. Furtado, A. Baylin, and H. Campos Some Dietary and Adipose Tissue Carotenoids Are Associated with the Risk of Nonfatal Acute Myocardial Infarction in Costa Rica J. Nutr., July 1, 2005; 135(7): 1763 - 1769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D Sesso, J. E Buring, E. P Norkus, and J M. Gaziano Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men Am. J. Clinical Nutrition, May 1, 2005; 81(5): 990 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Knekt, J. Ritz, M. A Pereira, E. J O'Reilly, K. Augustsson, G. E Fraser, U. Goldbourt, B. L Heitmann, G. Hallmans, S. Liu, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1508 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Hak, J. Ma, C. B. Powell, H. Campos, J. M. Gaziano, W. C. Willett, and M. J. Stampfer Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke Stroke, July 1, 2004; 35(7): 1584 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Dwyer, M. J. Paul-Labrador, J. Fan, A. M. Shircore, C. N. B. Merz, and K. M. Dwyer Progression of Carotid Intima-Media Thickness and Plasma Antioxidants: The Los Angeles Atherosclerosis Study Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 313 - 319. [Abstract] [Full Text]
|
|
|
|
|
|
H. D Sesso, J. E Buring, E. P Norkus, and J M. Gaziano Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women Am. J. Clinical Nutrition, January 1, 2004; 79(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Dwyer, H. Allayee, K. M. Dwyer, J. Fan, H. Wu, R. Mar, A. J. Lusis, and M. Mehrabian Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis N. Engl. J. Med., January 1, 2004; 350(1): 29 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Herron and M. L. Fernandez Are the Current Dietary Guidelines Regarding Egg Consumption Appropriate? J. Nutr., January 1, 2004; 134(1): 187 - 190. [Full Text] [PDF]
|
|
|
|
|
|
H. Wu, K. M Dwyer, Z. Fan, A. Shircore, J. Fan, and J. H Dwyer Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1085 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F S Benjaminov, M Prentice, K W Sniderman, S Siu, P Liu, and F Wong Portopulmonary hypertension in decompensated cirrhosis with refractory ascites Gut, September 1, 2003; 52(9): 1355 - 1362. [Abstract] [Full Text]
|
|
|
|
|
|
S. Blakely, A. Herbert, M. Collins, M. Jenkins, G. Mitchell, E. Grundel, K. R. O'Neill, and F. Khachik Lutein Interacts with Ascorbic Acid More Frequently than with {alpha}-Tocopherol to Alter Biomarkers of Oxidative Stress in Female Zucker Obese Rats J. Nutr., September 1, 2003; 133(9): 2838 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Hak, M. J. Stampfer, H. Campos, H. D. Sesso, J. M. Gaziano, W. Willett, and J. Ma Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians Circulation, August 19, 2003; 108(7): 802 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K Osganian, M. J Stampfer, E. Rimm, D. Spiegelman, J. E Manson, and W. C Willett Dietary carotenoids and risk of coronary artery disease in women Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1390 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Crouse III, R. Tang, M. A. Espeland, J. G. Terry, T. Morgan, and M. Mercuri Associations of Extracranial Carotid Atherosclerosis Progression With Coronary Status and Risk Factors in Patients With and Without Coronary Artery Disease Circulation, October 15, 2002; 106(16): 2061 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alves-Rodrigues and B. Thomas The role of lutein in the prevention of atherosclerosis J. Am. Coll. Cardiol., August 21, 2002; 40(4): 835 - 835. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alves-Rodrigues and B. Thomas Fruit and Vegetable Intake and Coronary Heart Disease Ann Intern Med, July 16, 2002; 137(2): 143 - 144. [Full Text] [PDF]
|
|
|
|
|
|
K. J. Joshipura, F. B. Hu, and W. C. Willett Fruit and Vegetable Intake and Coronary Heart Disease Ann Intern Med, July 16, 2002; 137(2): 144 - 144. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Din DIET AND CARDIOVASCULAR DISEASE Am J Public Health, July 1, 2002; 92(7): 1050 - 1051. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Mares-Perlman, A. E. Millen, T. L. Ficek, and S. E. Hankinson The Body of Evidence to Support a Protective Role for Lutein and Zeaxanthin in Delaying Chronic Disease. Overview J. Nutr., March 1, 2002; 132(3): 518S - 524. [Abstract] [Full Text] [PDF]
|
|